Why the US is sitting on proven Ebola vaccines

The US owns a patent on Ebola. They have several different vaccines that have proven to be very effective in initial clinical trials. But thanks to a winding, abysmal bureaucracy and complicit pharmaceutical companies, those vaccines language on government shelves. Why? Because it takes a lot of money to push a drug through FDA approvals, and no one sees a return of that money with an Ebola cure. Can you guess why? The Resident breaks it down.

Follow The Resident at http://www.twitter.com/TheResident
Find RT America in your area: http://rt.com/where-to-watch/
Or watch us online: http://rt.com/on-air/rt-america-air/

Like us on Facebook http://www.facebook.com/RTAmerica
Follow us on Twitter http://twitter.com/RT_America


News, Russia Today

Leave a Reply